A 58-year-old man on long-term phenytoin therapy for epilepsy develops fever, rash, lymphadenopathy, and elevated liver enzymes 3 weeks after starting the drug. You suspect drug reaction with eosinophilia and systemic symptoms (DRESS). Which investigation is most specific for confirming the diagnosis?

Explanation

## Diagnosis of DRESS Syndrome (Type IV Hypersensitivity ADR) ### Clinical Context The patient presents with the classic tetrad of **DRESS syndrome** (Drug Reaction with Eosinophilia and Systemic Symptoms): - Delayed onset (2–6 weeks post-drug initiation) - Fever, rash, lymphadenopathy - Eosinophilia and atypical lymphocytes - Hepatitis/multi-organ involvement This is a **Type IV hypersensitivity** reaction (T-cell mediated), not Type I. ### Investigation of Choice: Lymphocyte Stimulation Test (LST) / Lymphocyte Transformation Test (LTT) **Key Point:** LST/LTT is the most specific in vitro test for confirming drug-specific T-cell sensitization in DRESS and other Type IV ADRs. #### Mechanism of LST/LTT 1. **Patient's lymphocytes** are cultured in vitro with the suspected drug (or its metabolite) 2. **Drug-specific T cells** proliferate (if sensitized) 3. **Proliferation is measured** by: - Tritiated thymidine (³H-thymidine) incorporation (classic) - CFSE (carboxyfluorescein succinimidyl ester) flow cytometry (modern) - Stimulation Index (SI) = cpm with drug / cpm without drug 4. **SI ≥3** is considered positive **High-Yield:** LST/LTT directly demonstrates **drug-specific T-cell activation**, which is the pathophysiological basis of Type IV ADRs. ### Comparison of Investigations in DRESS Syndrome | Investigation | What It Shows | Specificity for DRESS | Timing | Limitations | |---|---|---|---|---| | **Peripheral blood smear** | Eosinophilia, atypical lymphocytes | Low (non-specific) | Acute | Present in many conditions (infections, leukemia, other ADRs) | | **Skin biopsy** | Interface dermatitis, lymphocytic infiltrate | Moderate (supports diagnosis) | Acute | Histology is non-specific; does not prove drug causation | | **LST/LTT** | Drug-specific T-cell proliferation | **High (most specific)** | Acute or delayed | Requires specialized lab; not widely available; 70–80% sensitive | | **Liver biopsy** | Drug-induced hepatitis pattern | Moderate (supports diagnosis) | Acute | Invasive; does not prove drug causation; histology can mimic viral hepatitis | **Clinical Pearl:** LST/LTT is the **only investigation that directly links the drug to T-cell sensitization**, making it the gold standard for confirming Type IV hypersensitivity. ### Why LST/LTT is Superior ```mermaid flowchart TD A[DRESS Syndrome Suspected]:::outcome --> B{Confirm drug-specific T-cell activation?}:::decision B -->|Yes: LST/LTT positive| C[Type IV Hypersensitivity confirmed]:::outcome B -->|No: LST/LTT negative| D[Consider other diagnoses]:::action E[Peripheral blood smear] -->|Shows eosinophilia| F[Non-specific finding]:::outcome G[Skin/Liver biopsy] -->|Shows inflammation| H[Supports diagnosis but not pathognomonic]:::outcome I[LST/LTT] -->|Drug-specific T cells| J[Definitive immunological proof]:::action ``` **Mnemonic:** **LST = L (Lymphocyte), S (Stimulation), T (Test) — directly proves drug-specific T-cell sensitization** ### Diagnostic Criteria for DRESS (RegiSCAR Scoring) LST/LTT is not part of the formal RegiSCAR score but is a **supporting investigation** that confirms the immunological mechanism when positive. ### Timing Considerations - **Acute phase (during reaction):** LST/LTT may be positive (best sensitivity) - **After resolution:** Sensitivity decreases over weeks/months - **Optimal window:** Within 2–4 weeks of reaction onset **Warning:** LST/LTT is **not available in all laboratories** and requires specialized immunology expertise. In routine practice, diagnosis is clinical + supportive investigations (CBC, LFTs, skin biopsy). However, for **exam purposes**, LST/LTT is the most specific confirmatory test.